Spectrum Brands’ Empower Brands offers to buy Helen of Troy for $37 per share
Bitget2026/11/04 12:12Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Empower Brands, jointly owned by Spectrum Brands and Oaktree-managed funds, proposed buying Helen of Troy for $37 per share in cash.
- The proposal implies an enterprise value of approximately $1.6 billion, offering a 28% premium to Helen of Troy’s October 30, 2026, close.
- The offer increased to $37 per share on October 12, 2026, from the initial $34 proposal submitted August 19, 2026.
- Helen of Troy deemed the increased proposal inadequate on October 20, 2026; no definitive agreement has been reached.
- Funding would comprise existing cash, new equity and third-party debt, with no financing contingency; Empower’s debt would be non-recourse to Spectrum.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spectrum Brands Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261104705592) on November 04, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
格隆汇•2026/11/09 07:01

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
智通财经•2026/11/09 06:41

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
智通财经•2026/11/09 06:41

Crypto prices
MoreBitcoin
BTC
$74,042.84
-2.25%
Ethereum
ETH
$2,100.87
-5.86%
Tether USDt
USDT
$0.9988
+0.02%
BNB
BNB
$680.94
-2.37%
USDC
USDC
$0.9999
+0.00%
XRP
XRP
$1.09
-6.49%
Solana
SOL
$85.71
-3.65%
TRON
TRX
$0.3165
-1.18%
Zcash
ZEC
$1,208.72
-4.15%
Hyperliquid
HYPE
$74.06
-3.90%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now